The static record of your science, made legible enough to persuade and precise enough to defend.
A figure carries weight that prose cannot. It is what a reviewer studies, what an investor screenshots, what a regulator returns to.
A figure carries weight that prose cannot. It is what a reviewer studies, what an investor screenshots, what a regulator returns to.
What we do
When the science is complex, a single well-built visual can move a decision that a page of explanation cannot.
We build that work at the intersection of two disciplines that rarely sit together: board-certified medical illustrators and PhD-level scientists and writers, side by side. Every visual is scientifically defensible before it is beautiful, and every one is made for a specific audience at a specific moment, to move a specific decision forward. This is the static estate, from raw data to publication-ready figure. When the science needs to move, that is Animation & Motion, and the two are built to work as one system.
Services
Charts, graphs, and quantitative displays built for scientific rigor and communication clarity at once. We work with complex, multi-variable datasets and produce figures that make the science legible without flattening it, for publications, grant applications, investor materials, and regulatory submissions.
Visual representations of a therapeutic or platform pipeline for investor materials, corporate sites, and congress communications. Built to convey progress, differentiation, and opportunity to audiences that range from specialist scientists to generalist investors, without either losing the plot.
Distilled research summaries and visual abstracts for science journalism, congress materials, global health communications, and public-facing platforms. The work of making a dense finding graspable in a single, credible frame.
For global health and research organizations, data visualization that is built to be acted on. We retain the nuance in the data while crystallizing the takeaway, so a busy decision-maker reaches the right conclusion faster and with more confidence.
Who this is for
Biotech and pharma teams
Preparing investor materials, regulatory filings, or scientific publications.
Global health organizations
Turning research findings and program outcomes into something audiences with very different scientific fluency can read.
Discovery-stage and platform companies
Making novel technology legible for partners and funders.
Teams whose figures lag their data
Any team whose data is strong and whose figures are not yet doing it justice.
The moments we're built for
A fundraise or partnership where the figures have to survive diligence.
A clinical readout that needs its data framed with precision.
A new discovery whose significance is still trapped in the lab.
A public health crisis where the picture has to stay legible while it keeps changing.
Selected work
Sana Biotechnology
Platform diagrams built for its S-1 and investor engagements.
TriSalus Life Sciences
A library of scientific illustration and figures for a novel cancer platform.
UW STD Prevention Training Center
Self-test visual guides now used in 22 languages.
The COVID-19 case study
Figures published in Nature and used by institutions worldwide.
Related capabilities
Common questions
The static estate: data visualization and scientific figures, pipeline and portfolio graphics, visual abstracts, and strategic data visualization built to be acted on. When the mechanism has to move, that is Animation & Motion.
Board-certified medical illustrators working alongside PhD scientists and science writers. The biology is settled before the figure is designed, not corrected after.
Yes. We build for journals, grant applications, investor materials, and regulatory submissions, with MLR and regulatory review anticipated in the annotation and the file structure rather than bolted on at the end.
Your primary data, the paper or protocol behind it, and the one decision the figure has to support. If the numbers are still moving, we start with the argument and build the figure to accept the final data.
Talk to us about your visualization.